Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Fonseca

Showing results (91-100 of 358) with videos related to

Pageof 36
Sort By:
European Journal of Haematology|December 21, 2025
Ferritin H Knockout Induces Differential Immunomodulatory Drug Responses in Multiple Myeloma Cell LinesAarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, et al.
Blood Cancer Journal|October 16, 2025
Sex-specific dysregulation of exosomal non-coding RNAs drives multiple myeloma progressionSamaneh Maleknia, Sanam Rezaei Benam, Greg Ahmann, et al.
Oncotarget|August 18, 2016
PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationPhaik Ju Teoh, Chonglei Bi, Chirackal Sintosebastian, et al.
American Journal of Hematology|November 25, 2021
Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patientsMariano Arribas, Greg J Ahmann, Skye Buckner Petty, et al.
Analytical and Bioanalytical Chemistry|May 1, 2019
Glassy carbon electrode modified with carbon black and cross-linked alginate film: a new voltammetric electrode for paraquat determinationMilena Rafalski Pacheco, Sergiane Caldas Barbosa, Rafael Fonseca Neves Quadrado, et al.
Journal of Pain and Symptom Management|May 12, 2012
Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale constructionLynne I Wagner, Don Robinson, Matthias Weiss, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2023
Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature ReviewRafael Fonseca, Diana Tran, Alyshia Laidlaw, et al.
BMC Plant Biology|February 14, 2019
Transcriptional profiling of methyl jasmonate-induced defense responses in bilberry (Vaccinium myrtillus L.)Rafael Fonseca Benevenuto, Tarald Seldal, Stein Joar Hegland, et al.
Haematologica|May 30, 2013
Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myelomaScott Van Wier, Esteban Braggio, Angela Baker, et al.
Hematology, Transfusion and Cell Therapy|December 24, 2025
Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell linesAarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, et al.
Pageof 36

Showing results (91-100 of 358) with videos related to

Sort By:
Pageof 36
European Journal of Haematology|December 21, 2025
Ferritin H Knockout Induces Differential Immunomodulatory Drug Responses in Multiple Myeloma Cell LinesAarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, et al.
Blood Cancer Journal|October 16, 2025
Sex-specific dysregulation of exosomal non-coding RNAs drives multiple myeloma progressionSamaneh Maleknia, Sanam Rezaei Benam, Greg Ahmann, et al.
Oncotarget|August 18, 2016
PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationPhaik Ju Teoh, Chonglei Bi, Chirackal Sintosebastian, et al.
American Journal of Hematology|November 25, 2021
Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patientsMariano Arribas, Greg J Ahmann, Skye Buckner Petty, et al.
Analytical and Bioanalytical Chemistry|May 1, 2019
Glassy carbon electrode modified with carbon black and cross-linked alginate film: a new voltammetric electrode for paraquat determinationMilena Rafalski Pacheco, Sergiane Caldas Barbosa, Rafael Fonseca Neves Quadrado, et al.
Journal of Pain and Symptom Management|May 12, 2012
Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale constructionLynne I Wagner, Don Robinson, Matthias Weiss, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 15, 2023
Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature ReviewRafael Fonseca, Diana Tran, Alyshia Laidlaw, et al.
BMC Plant Biology|February 14, 2019
Transcriptional profiling of methyl jasmonate-induced defense responses in bilberry (Vaccinium myrtillus L.)Rafael Fonseca Benevenuto, Tarald Seldal, Stein Joar Hegland, et al.
Haematologica|May 30, 2013
Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myelomaScott Van Wier, Esteban Braggio, Angela Baker, et al.
Hematology, Transfusion and Cell Therapy|December 24, 2025
Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell linesAarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, et al.
Pageof 36